These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 1675052)

  • 1. Thiol-independent stimulation of soluble guanylate cyclase by NO-containing compounds.
    Niroomand F; Mülsch A; Böhme E
    Biochem Pharmacol; 1991 Jun; 41(11):1777-9. PubMed ID: 1675052
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparison of the effects of SIN-1, sodium nitroprusside and nitrate derivatives on the inhibition of blood platelet aggregation and activation of soluble platelet guanylate-cyclase].
    Karrenbrock B; Grewe R; Loeschke K; Gerzer R
    Pathol Biol (Paris); 1987 Feb; 35(2 Pt 2):251-4. PubMed ID: 2882462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of guanylate cyclase and the regulatory role of cyclic 3',5'-guanosine monophosphate.
    Severina IS
    Biochem Int; 1988 Aug; 17(2):265-78. PubMed ID: 2903739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Under anaerobic conditions, soluble guanylate cyclase is specifically stimulated by glutathione.
    Niroomand F; Rössle R; Mülsch A; Böhme E
    Biochem Biophys Res Commun; 1989 May; 161(1):75-80. PubMed ID: 2567167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulation of human platelet guanylate cyclase by nitroso compounds.
    Yamakado T; Nishikawa M; Hidaka H
    Thromb Res; 1982 Apr; 26(2):135-40. PubMed ID: 6126017
    [No Abstract]   [Full Text] [Related]  

  • 6. Soluble guanylate cyclase activation by nitric oxide and its reversal. Involvement of sulfhydryl group oxidation and reduction.
    Braughler JM
    Biochem Pharmacol; 1983 Mar; 32(5):811-8. PubMed ID: 6132608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversible activation of soluble guanylate cyclase by oxidizing agents.
    Wu XB; Brüne B; von Appen F; Ullrich V
    Arch Biochem Biophys; 1992 Apr; 294(1):75-82. PubMed ID: 1347985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guanylate cyclase activation of nitroprusside and nitrosoguanidine is related to formation of S-nitrosothiol intermediates.
    Ignarro LJ; Barry BK; Gruetter DY; Edwards JC; Ohlstein EH; Gruetter CA; Baricos WH
    Biochem Biophys Res Commun; 1980 May; 94(1):93-100. PubMed ID: 6104490
    [No Abstract]   [Full Text] [Related]  

  • 9. [Conditions of activation of guanylate cyclase from human platelets].
    Chirkov IuIu; Tyshchuk IA; Severina IS
    Biokhimiia; 1988 Sep; 53(9):1520-6. PubMed ID: 2904828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The involvement of catalytic site thiol groups in the activation of soluble guanylate cyclase by sodium nitroprusside.
    Kamisaki Y; Waldman SA; Murad F
    Arch Biochem Biophys; 1986 Dec; 251(2):709-14. PubMed ID: 2879512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methemoglobin blockade of coronary arterial soluble guanylate cyclase activation by nitroso compounds and its reversal with dithiothreitol.
    Ohlstein EH; Barry BK; Gruetter DY; Ignarro LJ
    FEBS Lett; 1979 Jun; 102(2):316-20. PubMed ID: 37124
    [No Abstract]   [Full Text] [Related]  

  • 12. Requirement for heme in the activation of purified guanylate cyclase by nitric oxide.
    Craven PA; DeRubertis FR
    Biochim Biophys Acta; 1983 Jun; 745(3):310-21. PubMed ID: 6134553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of carnosine on the activation of human platelet soluble guanylate cyclase by sodium nitroprusside and protoporphyrin IX.
    Severina IS; Busygina OG
    Biochem Int; 1990 Nov; 22(3):455-65. PubMed ID: 1981669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analogy and differences in properties of soluble forms of guanylate cyclase of the heart and rat blood platelets].
    Miroshnichenko VP; Busygina OG; Severina IS
    Vopr Med Khim; 1989; 35(4):60-6. PubMed ID: 2573196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of soluble guanylate cyclase by nitrovasodilators is inhibited by oxidized low-density lipoprotein.
    Schmidt K; Graier WF; Kostner GM; Mayer B; Kukovetz WR
    Biochem Biophys Res Commun; 1990 Oct; 172(2):614-9. PubMed ID: 1978674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of heme in activating rat myocardial guanylate cyclase by sodium nitroprusside].
    Miroshnichenko VP; Severina IS
    Biokhimiia; 1995 Apr; 60(4):499-507. PubMed ID: 7779974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Soluble forms of guanylate cyclases: mechanism of activation by nitrogen oxide and role in platelet aggregation].
    Severina IS
    Vestn Ross Akad Med Nauk; 1995; (2):41-6. PubMed ID: 7756930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytoprotection of human polymorphonuclear leukocytes by stimulators of adenylate and guanylate cyclases.
    Korbut R; Trabka-Janik E; Gryglewski RJ
    Eur J Pharmacol; 1989 Jun; 165(1):171-2. PubMed ID: 2475351
    [No Abstract]   [Full Text] [Related]  

  • 19. Benzodifuroxan as an NO-dependent activator of soluble guanylate cyclase and a novel highly effective inhibitor of platelet aggregation.
    Bussygina OG; Pyatakova NV; Khropov YV; Ovchinnikov IV; Makhova NN; Severina IS
    Biochemistry (Mosc); 2000 Apr; 65(4):457-62. PubMed ID: 10810184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of rat myometrial guanylate cyclase activities by sodium nitroprusside and unsaturated fatty acids.
    Leiber D; Harbon S
    Biochem Biophys Res Commun; 1979 Jul; 89(2):598-606. PubMed ID: 39561
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.